GLTO
GLTO
NASDAQ · Biotechnology

Galecto Inc

$25.50
-0.13 (-0.51%)
As of Mar 29, 10:51 PM ET ·
Financial Highlights (FY 2025)
Revenue
7.65M
Net Income
-2,097,514
Gross Margin
31.0%
Profit Margin
-27.4%
Rev Growth
+8.4%
D/E Ratio
0.85
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 31.0% 31.0% 31.0%
Operating Margin -19.6% -21.6% -18.5%
Profit Margin -27.4% -21.1% -22.4%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 7.65M 7.80M 6.88M
Gross Profit 2.37M 2.42M 2.13M
Operating Income -1,495,930 -1,684,978 -1,270,263
Net Income -2,097,514 -1,645,262 -1,540,052
Gross Margin 31.0% 31.0% 31.0%
Operating Margin -19.6% -21.6% -18.5%
Profit Margin -27.4% -21.1% -22.4%
Rev Growth +8.4% +22.8% +24.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 12.99M 11.77M 13.15M
Total Equity 15.26M 17.60M 16.68M
D/E Ratio 0.85 0.67 0.79
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -2,154,773 -2,236,853 -1,912,817
Free Cash Flow -1,120,093 -988,846 -1,121,747